Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.
- DOI
- 10.1038/s41392-026-03049-w
- Published
- 2026 Nov 10
- Container
- Signal transduction and targeted therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41392-026-03049-w,
title = {Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.},
author = {Trouvilliez S and Cicero J and Chow SYA and Ikeuchi Y and Toillon RA},
year = {2026},
journal = {Signal transduction and targeted therapy},
doi = {10.1038/s41392-026-03049-w},
url = {https://doi.org/10.1038/s41392-026-03049-w}
}RIS
TY - JOUR TI - Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA. AU - Trouvilliez S AU - Cicero J AU - Chow SYA AU - Ikeuchi Y AU - Toillon RA PY - 2026 JO - Signal transduction and targeted therapy DO - 10.1038/s41392-026-03049-w UR - https://doi.org/10.1038/s41392-026-03049-w ER -
APA
S, T., J, C., SYA, C., Y, I., & RA, T. (2026). Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-03049-w
Source records
- pubmed · retrieved 2026-11-10T18:05:05.953Z